Page last updated: 2024-08-25

squalamine and Pleural Effusion

squalamine has been researched along with Pleural Effusion in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allgood, V; Bekele, BN; Carbone, DP; Desai, A; Hait, H; Hammond, LA; Herbst, RS; Holroyd, KJ; Schiller, JH; Solomon, S; Tran, HT; Williams, JI1

Trials

1 trial(s) available for squalamine and Pleural Effusion

ArticleYear
A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Sep-15, Volume: 9, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cholestanols; Disease-Free Survival; Female; Humans; Infusions, Intravenous; Lactates; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Patient Selection; Pleural Effusion; Survival Analysis; Time Factors

2003